Analysis of Factors Causing Skin Damage in the Application of Peripherally Inserted Central Catheter in Cancer Patients
Table 1
Comparison of skin injury in PICC catheterization with different data (n = 202).
Item
Skin injury of PICC catheter
Incidence of skin injury (%)
χ2/Z
value
No
Yes
Sex (case)
Male
62
19
23.5
0.122
0.727
Female
90
31
25.6
Diabetes
Yes
37
10
21.3
0.397
0.528
No
115
40
25.8
Stay in bed
Yes
14
3
17.7
0.503
0.478
No
138
47
25.4
Allergy history
Yes
8
5
38.5
1.402
0.236
No
144
45
23.8
Skin characteristics
Oiliness
15
8
34.8
1.430
0.489
Neutral
122
37
23.3
Dryness
15
5
25.0
Category of chemotherapeutic drugs
Vesicant
27
8
22.9
2.839
0.242
Non bullous
125
42
25.1
Whether or not use of hormones
Yes
124
47
27.5
4.468
0.035
No
28
3
9.7
History of radiotherapy
Yes
32
15
31.9
1.687
0.194
No
120
35
22.6
Days with tube
≤90
25
25
50.0
26.230
<0.001
91–180
84
22
20.8
≥181
43
3
6.5
Specialist nurse
Yes
101
38
27.3
1.600
0.206
No
51
12
19.1
Chemotherapy cycle
<IV stage
19
23
54.8
25.638
<0.001
≥IV stage
133
27
16.9
Age (years)
[61.0 (53.0, 67.0)]
[56.5 (40.0, 65.2)]
−1.792
0.073
BMI
[23.6 (21.5, 27.7)]
[24.5 (22.8, 27.9)]
−2.443
0.015
Self care ability (score)
[90.0 (85.0, 100.0)]
[100.0 (88.8, 100.0)]
−1.968
0.049
The data are nonnormal distribution after normal test. Vesicant: Drugs can damage the vascular wall and cause irreversible inflammatory changes. Non-bullous: Drugs can damage the blood vessel wall and cause reversible inflammatory changes.
